Also from this source

You just read:

CureVac Announces Phase I/IIa Clinical Study Data of its mRNA Cancer Immunotherapy in Prostate Cancer Published in the Journal for ImmunoTherapy of Cancer

News provided by

CureVac

Jul 07, 2015, 07:00 ET